Cargando…

Serotonin 5-HT(2A) receptor activity mediates adipocyte differentiation through control of adipogenic gene expression

Serotonin 5-HT(2) receptors are expressed in many tissues and play important roles in biological processes. Although the 5-HT(2A) receptor is primarily known for its role in central nervous system, it is also expressed in peripheral tissues. We have found that 5-HT(2A) receptor antagonists inhibit h...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Bangning, Battaglia, Diana M., Foster, Timothy P., Nichols, Charles D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492876/
https://www.ncbi.nlm.nih.gov/pubmed/34611182
http://dx.doi.org/10.1038/s41598-021-98970-1
Descripción
Sumario:Serotonin 5-HT(2) receptors are expressed in many tissues and play important roles in biological processes. Although the 5-HT(2A) receptor is primarily known for its role in central nervous system, it is also expressed in peripheral tissues. We have found that 5-HT(2A) receptor antagonists inhibit human subcutaneous primary adipocyte differentiation. We also show that siRNA knockdown of the 5-HT(2A) receptor blocks differentiation. Using gene expression analysis in combination with receptor antagonists we found that activity of 5-HT(2A) receptors is necessary very early in the differentiation process to mediate expression of adipogenic genes, including peroxisome proliferator-activated receptor gamma (ppar-γ), adipocyte protein 2 (aP2), adiponectin, and serine/threonine-protein kinase 1 (sgk1). We show here for the first time that 5-HT(2A) receptor activity is necessary for differentiation of human primary subcutaneous preadipocytes to adipocytes, and that 5-HT(2A) receptor activity mediates key genes related to adipogenesis during this process. Importantly, this work contributes to a greater understanding of the adipocyte differentiation process, as well as to the role of 5-HT(2A) receptors in peripheral tissues, and may be relevant to the development of novel therapeutic strategies targeting this receptor for the treatment of obesity related diseases.